Cannabidiol (CBD) Stimulates Healing At A Cellular Level

What makes CBD unique is that it uses something called the “Endocannabinoid” system in your body. The endocannabinoid system regulates the proper function of cells throughout your entire body. That’s why people taking CBD notice an improvement in many areas.

There are tens of thousands scientific research studies proving the effectiveness of CBD on dozens of different ailments. Here is a small sample of what we found:

Reduces Seizures 

In a 2013 case study published in the Journal of Epilepsy and Behavior, children in the study we taking an average of 12 anti-seizure drugs. After introducing CBD, 84% of the families reported an improvement not only with seizures but also increased alertness, improved mood and better sleep.

Combats Cancer Cells 

Recently the NCI (National Cancer Institute) published a press release stating that studies have show cannabinoids may be able to impcbd-oil-medicinals-hemp-oil-fight-canceract cancer cells while protecting normal cells.

Decreases Pain 

Thousands of studies have shown that Cannabinoids such as CBD shows great promise for the management and treatment of pain.

Reduces Oxidative Stress and Inflammation

Cannabidiol may have utility in treating a number of human diseases and disorders now known to involve activation of the immune system and associated oxidative stress. These include rheumatoid arthritis, types 1 and 2 diabetes, atherosclerosis, Alzheimer disease, hypertension, the metabolic syndrome, ischemia–reperfusion injury, depression, and neuropathic pain. [1]

Helps Get Rid Of Muscle Spasms and Stiffness

Studies have demonstrated that medical cannabis offers significant improvements in muscle spasticity, both in mice trials and in human subjects [2][3]

There’s strong evidence that suggests that cannabinoid-induced reductions in muscle tremors and spasticity are due to the activation of the cannabinoid receptors within the endocannabinoid system[4]. THC and CBD have demonstrated that they both activate the CB1 and CB2 receptors and their actions on the two receptors regulates the excitatory and inhibitory neurotransmitters necessary to curtail spasms [5] (6).

For those whose spasms and spasms are related to multiple sclerosis, cannabis has demonstrated it can offer relief [7]. In what was the largest multinational clinical trial of its kind, multiple sclerosis patients suffering from spasms were treated with cannabis containing THC and CBD. After 4-12 weeks, the patients experienced significantly reduced spasticity severity compared with patients receiving the placebo. In another study, approximately two-thirds of patients reported improvements in spasticity after 50 weeks of treatment with cannabis containing THC and CBD [8].

Cannabis has even shown to be effectively lower the frequency and intensity of spasms in multiple sclerosis patients whose spasms had been previously unrelieved by traditional anti-spasticity therapy. After 15 weeks of treatment, patients saw a significant reduction in spasticity. Improvements were seen within the first four weeks [9].

 

Scientific research studies have proved the effectiveness of CBD for

CBD ailments

 

 

 

 

Sources:

  1. Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.
    Free Radic Biol Med. 2011 Sep 1;51(5):1054-61. doi: 10.1016/j.freeradbiomed.2011.01.007. Epub 2011 Jan 14.
    https://www.ncbi.nlm.nih.gov/pubmed/21238581
  2. The pharmacologic and clinical effects of medical cannabis
    https://www.ncbi.nlm.nih.gov/pubmed/23386598
  3. Cannabinoids control spasticity and tremor in a multiple sclerosis model
    http://www.nature.com/nature/journal/v404/n6773/abs/404084a0.html
  4. CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931565/
  5. Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325203/
  6. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
    https://www.ncbi.nlm.nih.gov/pubmed/12137404
  7. Do cannabinoids reduce multiple sclerosis-related spasticity?
    https://www.ncbi.nlm.nih.gov/pubmed/19901724
  8. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
    https://www.ncbi.nlm.nih.gov/pubmed/24854329
  9. Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis
    http://msj.sagepub.com/content/16/6/707.short

 

 

 

 

 

 

 

 

 

 

No Comments

Post A Comment